New bipartisan bill aims to speed up clinical trials for rare disease treatments
CNBC
A new bipartisan bill aims to speed rare disease drug development by making clinical trials faster, cheaper and more accessible to patients.
Read the full story
This is a short summary. The complete article is published by CNBC.
Headline and summary aggregated from public news feeds. For information only — not financial advice.